Home
About us
Meetings
Abstracts
- Submission guidelines
My profile

Oral Presentation: Applications

Home / Oral Presentation: Applications / Page 4

Oral Presentation: Applications

A modeling framework to simulate Xeloda dose intensity and survival in colorectal cancer

Thursday 16 October, 2025

Objectives: Capecitabine (Xeloda®) is approved for colorectal cancer (“CRC”) as a monotherapy at 1250 mg/m2 BID x 14 days every…

Posts navigation

Newer posts

PAGE Meeting (Population Approach Group Europe)

Follow us on:
info@page-meeting.org

Design & Development: Interpulse

Privacy settings

To provide the best experiences, we use technologies such as cookies to store and/or access device information. By consenting to this, we may process data such as browsing behavior or unique IDs on this site. Not giving consent or withdrawing consent may adversely affect certain features and functions.

Functional Functional Always active

To provide the best experiences, we use technologies such as cookies to store and/or access device information. By consenting to this, we can process data such as browsing behavior or unique IDs on this site. Not giving consent or withdrawing consent may adversely affect certain features and functionalities.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for statistical purposes.

Marketing Marketing

De technische opslag of toegang is vereist om gebruikersprofielen aan te maken voor het verzenden van advertenties of om de gebruiker te volgen op een website of over meerdere websites voor vergelijkbare marketingdoeleinden.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}